The Federal IDR Final Rule changed which disputes are worth filing. Here's what to do first.

For three years, your federal IDR (Independent Dispute Resolution) strategy has been governed by a single, quiet constraint: The arbitration fee was so high that thousands of legitimate out-of-network (OON) claims were never worth disputing.  

That math just changed overnight, and the service lines you wrote off as uneconomical are back in play. This guide shows you exactly what the new Federal IDR Operations Final Rule (CMS-9897-F) changes, why it changes your threshold economics, and the specific steps to take before the fee reduction takes effect. 

How much did the IDR administrative fee decrease? 

The per-party administrative fee for a federal IDR dispute falls from $115 to $15 – an 87% reduction.  

The Departments estimate this reduction from $115 to $15 transfers roughly $504 million annually back to disputing parties. 

That $115 fee existed because the IDR process was drowning. Since launching in April 2022, the system has received more than 5 million disputes,  a volume that vastly exceeded the Departments' original projections and created the backlogs that made a high fee feel necessary. The fee was a rationing tool, and it worked by pricing your smaller claims out of the process entirely. 

Now consider what that meant in practice. At $115 per party, a single low-dollar anesthesia or radiology claim rarely cleared the breakeven line. The fee alone consumed most of the expected recovery. So those claims never entered the queue, not because they lacked merit, but because the arithmetic said no.  

How does the fee reduction change IDR dispute economics? 

Here is the mechanism that matters. Your IDR threshold model is a function of three variables: the administrative fee, the certified IDR entity fee, and your expected recovery net of internal labor. When the administrative fee drops 87%, the breakeven point for a viable dispute drops with it. 

The rule compounds this with a second change: Batching capacity expands from 25 to 50 qualified items per dispute.  

More lines per dispute means the fixed cost of arbitration spreads across twice the claim value. Per-line dispute cost falls on both axes at once. 

Most revenue cycle teams built their "is this worth disputing?" logic when the fee was $115. That logic now excludes claims that have become clearly profitable to pursue. The Departments themselves project a 30% increase in dispute volume driven by exactly this incentive shift. 

There's real money at stake in getting this right. Providers have historically prevailed in a strong majority of IDR disputes, with awards averaging well above the median in-network rate.  

Hospitals spent an estimated $5 billion cumulatively on IDR-related expenses from 2022 through 2024, per Congressional Research Service analysis (Report R48851). The rule doesn't just lower a fee,  it changes the return on a large, existing cost center. 

The key provisions at a glance 

Keep this table close as you brief your team. These are the operational levers the rule pulls. 

What should providers do now that the IDR fee has changed? 

The $15 fee applies to disputes initiated five business days after Federal Register publication, and the rule itself is effective August 3, 2026. The operational changes phase in on a rolling basis after that. That gives you a narrow planning window, not a long one. Focus here: 

1. Rebuild your threshold ROI models by specialty and service code. Any model built on a $115 fee is now wrong in the direction that costs you money. Rerun the breakeven using the $15 fee and 50-item batching capacity. Where the old rule was "dispute if expected recovery exceeds roughly $X," recalculate X for each high-volume, lower-dollar service line – anesthesia, radiology, pathology, and laboratory first, since those are where the batching configurations and the fee drop combine most powerfully. 

2. Build a batching strategy aligned to the three permitted groupings. The rule permits three configurations: a single-patient encounter; the same or comparable code across one or more patients; and the same Category I CPT code range for anesthesia, radiology, pathology, and laboratory. Map your OON denial inventory to these groupings now. The teams that pre-sort their claims into valid batches will file faster and cheaper than teams batching ad hoc. 

3. Tighten intake and eligibility screening. The rule raises the bar for a properly initiated dispute. There are new attestation requirements at initiation, and certified IDR entities now determine eligibility within five business days. If your intake process lets weak disputes through, you'll burn that fast eligibility clock on claims that were never going to qualify. Screen harder at the front so your filings hold up. 

4. Prepare your remittance tooling for CARC/RARC ingestion. Once code guidance publishes and becomes applicable, plans must use standardized codes on OON remittance to signal NSA scope and IDR eligibility. The Departments estimate this will strip out 146,250 to 219,375 ineligible disputes annually. Position your parsing tools to read those codes automatically, so eligibility determinations become a data step rather than a manual review. 

5. Plan for the IDR Gateway as a transition, not a cutover. Full platform functionality is anticipated within 24 months, with rolling guidance and feature launches beginning in Summer 2026. Treat this as a multi-phase migration. Assign an owner to track each guidance release, because several downstream deadlines – batching operational changes, registry applicability, open-negotiation reforms – are pegged to when the Departments announce specific portal functionality, not to a fixed calendar date. 

Where this gets difficult to do 

None of this is conceptually hard. The hard part is that your team is already at capacity, and this rule asks them to rebuild models, re-map inventory, and monitor a stream of rolling guidance, all at once, and mostly before the changes fully land. 

If you can only do one thing, do the threshold rebuild for your two highest-volume OON service lines. That single move captures most of the recoverable value, because the fee reduction hits high-volume, low-dollar claims hardest. Everything else, including full batching automation, CARC/RARC ingestion, Gateway migration, can follow in sequence once the economic case is proven on those first two lines.

The realistic risk isn't that you'll get the strategy wrong; it's that the guidance will roll out in pieces over 24 months, and a stretched team will miss a functionality announcement that starts a 90-day clock. Someone needs to own that calendar. 

Where EnableComp can help 

Resetting IDR threshold economics across every specialty and service code, and then keeping pace with rolling guidance for the next two years, is exactly the kind of complex-claims work that rewards scale and specialization.  

EnableComp models federal IDR ROI at the service-code level and manages the full dispute lifecycle, so your team captures the newly viable claims without absorbing the analytical and monitoring burden internally.  

If you want a service-line-by-service-line view of what the $15 fee and 50-item batching change for your specific denial inventory, let's build that model for your health system or hospital together.  Reach out today.

About the author 

Gordon Jaye, MPH, MScPM, is the Senior Vice President of Solution Engineering at EnableComp and a Six Sigma Black Belt. He brings extensive healthcare-operations leadership focused on optimizing patient access, patient satisfaction, and front-end revenue cycle efficiency. Gordon  specializes in strategies that improve patient flow, reduce wait times, and streamline intake through technology and process improvement. He is known for driving transformational change with rigorous financial oversight.